Veradigm | MDRX - Валовая прибыль





Валовая прибыль Изменить Дата
Alcidion AUD 21.02M 5.65M 2025-12
Ambu A/S DKK 975M 27M 2026-06
Amplifon EUR 130.09M 760.55M 2026-03
Cardinal Health USD 2.56B 62M 2026-06
Centene USD 13.82B 8.56B 2026-06
Charles River Laboratories USD 348.78M 69.47M 2026-06
Cigna USD 6.08B 50.37B 2026-03
Coloplast 4.74B 27M 2025-12
Convatec Group USD 660.5M 348.95M 2024-12
CVS Health USD 15.75B 125M 2026-06
Diasorin EUR 203M 17M 2026-06
Elevance Health USD 44.33B 32.65B 2026-06
General Electric Aerospace USD 4.46B 220M 2026-06
Gulf Medical Proj AED 46.22M 8.48M 2025-03
Humana USD 4.82B 754M 2025-06
IQVIA Holdings USD 1.44B 368M 2026-06
Laboratory Of America USD 1.11B 98.2M 2026-06
Maximus USD 348.8M 6.54M 2026-06
McKesson USD 3.68B 359M 2026-06
Med Life RON 681.6M 53.34M 2026-03
Molina Healthcare USD 1.43B 53M 2026-06
Omnicell USD 152.94M 12.57M 2026-06
Oriola-kd EUR 40.2M 2.1M 2025-09
Owens Minor USD 272.05M 20.92M 2025-12
Quest Diagnostics USD 906M 33M 2026-03
Rede D'or Sao Luiz BRL 3.22B 34.56M 2026-03
Siemens Healthineers EUR 2.14B 66M 2026-03
Sonova Holding CHF 1.28B 205.2M 2025-12
Supermax Corporation Bhd MYR -143.15M 161.11M 2025-09
UnitedHealth USD 98.66B 73.25B 2026-06
Veeva Systems USD 715.19M 36.58M 2026-06
Veradigm USD 83.44M 3.95M 2022-09
Xerox USD 441M 15M 2025-06